+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aminoglycosides Market by Product Type (Amikacin, Gentamicin, Neomycin), Route Administration (Injectable, Oral, Topical), Application, Distribution Channel, Formulation - Global Forecast 2025-2030- Product Image
Aminoglycosides Market by Product Type (Amikacin, Gentamicin, Neomycin), Route Administration (Injectable, Oral, Topical), Application, Distribution Channel, Formulation - Global Forecast 2025-2030- Product Image
Sale

Aminoglycosides Market by Product Type (Amikacin, Gentamicin, Neomycin), Route Administration (Injectable, Oral, Topical), Application, Distribution Channel, Formulation - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977762
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The aminoglycosides market is adapting rapidly as healthcare providers and manufacturers respond to shifting clinical demands, evolving resistance profiles, and a changing regulatory landscape. Senior decision-makers navigating this environment must understand the interplay of innovation, supply chain strategy, and regional policy in shaping future growth.

Market Snapshot: Aminoglycosides Market

The aminoglycosides market grew from USD 2.02 billion in 2024 to USD 2.12 billion in 2025. It is expected to continue expanding at a CAGR of 4.79%, reaching USD 2.67 billion by 2030. This trend highlights a resilient demand for advanced antibiotics capable of targeting severe bacterial infections, even as market participants confront complex clinical and commercial pressures.

Scope & Segmentation

  • Product Types: Amikacin, Gentamicin, Neomycin, Streptomycin, Tobramycin
  • Route Administration: Injectable (intramuscular, intravenous), Oral (capsules, tablets), Topical (ear drops, eye drops, skin creams)
  • Applications: Ambulatory surgical centers, Clinics, Hospital settings
  • Distribution Channels: Hospital pharmacy, Online pharmacy (marketplaces, pharmacy websites), Retail pharmacy, Wholesale distributors
  • Formulations: Ointment, Powder, Solution
  • Regions: Americas (U.S., Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the UK, Germany, France, UAE, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia, and more)
  • Key Players: Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Viatris Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Baxter International Inc., Amneal Pharmaceuticals Inc., Pfizer Inc., Dr. Reddy's Laboratories Ltd., Cipla Limited

Key Takeaways for Decision-Makers

  • Advances in drug delivery and dosing guidelines are making aminoglycoside antibiotics safer by reducing risks such as nephrotoxicity and ototoxicity in high-risk patient groups.
  • The industry is witnessing increased investment in partnerships that promote digital health integration, notably real-time drug monitoring and supply chain agility, reflecting new compliance imperatives.
  • Biosimilars and generics are intensifying competition, pushing established players to expand portfolios with enhanced or niche product strategies to maintain market access.
  • Growing regulatory emphasis on antimicrobial stewardship is influencing both R&D direction and healthcare provider behaviors, driving cross-disciplinary collaboration.
  • Manufacturers are prioritizing local production capabilities—especially in emerging economies and tariff-sensitive markets—to reinforce supply resilience and minimize exposure to international trade disruptions.

Tariff Impact: Strategic Operations and Supply Chains

U.S. tariffs introduced in 2025 have increased costs along the aminoglycosides supply chain, prompting companies to localize sourcing and strengthen partnerships with domestic suppliers. These shifts are also changing contract strategies and reinforcing just-in-time inventory approaches, while healthcare providers adjust procurement to ensure consistent availability. Advocacy for tariff exemptions on essential medicines and strategic stockpiling are now central to competitive positioning and risk management within the sector.

Methodology & Data Sources

This report combines a comprehensive secondary literature review with targeted primary interviews involving clinical experts, supply chain professionals, and regulators. These insights were validated through expert workshops and quantitative analysis, ensuring that trends and recommendations align closely with evolving operational realities and market priorities.

Aminoglycosides Market: Why This Report Matters

  • Delivers a structured, actionable view into current clinical, policy, and supply chain trends shaping strategic decisions in the aminoglycosides sector.
  • Enables more accurate resource planning, risk mitigation, and partnership approaches by offering granular segmentation and real-time competitive analysis.
  • Empowers executive leadership with clear guidance for innovation, operational optimization, and sustained market access against a backdrop of complex global shifts.

Conclusion

The aminoglycosides market is at a key inflection point, shaped by regulatory changes, technological evolution, and supply chain reconfiguration. Executive action based on data-driven insights and agile operational models will be critical to securing long-term performance in this industry.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Patent expirations driving competitive generic aminoglycoside market entries and pricing pressures
5.2. Advances in liposomal and nanoparticle delivery systems improving aminoglycoside therapeutic index
5.3. Growing use of therapeutic drug monitoring protocols to minimize nephrotoxicity in aminoglycoside treatments
5.4. Integration of aminoglycoside antibiotics in combination therapies for multidrug resistant Gram negative infections
5.5. Strategic collaborations accelerating development of next generation aminoglycoside analogs against superbugs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Aminoglycosides Market, by Product Type
8.1. Introduction
8.2. Amikacin
8.3. Gentamicin
8.4. Neomycin
8.5. Streptomycin
8.6. Tobramycin
9. Aminoglycosides Market, by Route Administration
9.1. Introduction
9.2. Injectable
9.2.1. Intramuscular
9.2.2. Intravenous
9.3. Oral
9.3.1. Capsules
9.3.2. Tablets
9.4. Topical
9.4.1. Ear Drops
9.4.2. Eye Drops
9.4.3. Skin Creams
10. Aminoglycosides Market, by Application
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Hospital
11. Aminoglycosides Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.3.1. Marketplaces
11.3.2. Pharmacy Websites
11.4. Retail Pharmacy
11.5. Wholesale Distributors
12. Aminoglycosides Market, by Formulation
12.1. Introduction
12.2. Ointment
12.3. Powder
12.4. Solution
13. Americas Aminoglycosides Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Aminoglycosides Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Aminoglycosides Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Ltd.
16.3.2. Sandoz International GmbH
16.3.3. Viatris Inc.
16.3.4. Fresenius Kabi AG
16.3.5. Hikma Pharmaceuticals PLC
16.3.6. Baxter International Inc.
16.3.7. Amneal Pharmaceuticals Inc.
16.3.8. Pfizer Inc.
16.3.9. Dr. Reddy's Laboratories Ltd.
16.3.10. Cipla Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. AMINOGLYCOSIDES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AMINOGLYCOSIDES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMINOGLYCOSIDES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. AMINOGLYCOSIDES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. AMINOGLYCOSIDES MARKET: RESEARCHAI
FIGURE 26. AMINOGLYCOSIDES MARKET: RESEARCHSTATISTICS
FIGURE 27. AMINOGLYCOSIDES MARKET: RESEARCHCONTACTS
FIGURE 28. AMINOGLYCOSIDES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AMINOGLYCOSIDES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AMINOGLYCOSIDES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AMINOGLYCOSIDES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY AMIKACIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY AMIKACIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GENTAMICIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GENTAMICIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY NEOMYCIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY NEOMYCIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY STREPTOMYCIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY STREPTOMYCIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOBRAMYCIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOBRAMYCIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY EAR DROPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY EAR DROPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY EYE DROPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY SKIN CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY SKIN CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY MARKETPLACES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY MARKETPLACES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PHARMACY WEBSITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PHARMACY WEBSITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY OINTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY OINTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 121. CANADA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. CANADA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. CANADA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 124. CANADA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 125. CANADA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 126. CANADA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 127. CANADA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 128. CANADA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 129. CANADA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 130. CANADA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 131. CANADA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. CANADA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. CANADA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. CANADA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. CANADA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 136. CANADA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 137. CANADA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 138. CANADA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 139. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 142. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 143. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 146. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 147. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 148. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 149. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 154. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 155. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 231. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 236. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 237. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 238. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 239. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 240. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 241. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 246. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 247. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 248. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 249. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 252. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 253. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 254. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 255. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 256. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 257. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 258. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 259. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 264. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 265. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 266. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 285. ITALY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. ITALY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. ITALY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 288. ITALY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 289. ITALY AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 290. ITALY AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 291. ITALY AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 292. ITALY AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 293. ITALY AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 294. ITALY AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 295. ITALY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. ITALY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. ITALY AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. ITALY AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. ITALY AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 300. ITALY AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 301. ITALY AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 302. ITALY AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 303. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 304. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 305. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 308. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 309. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 310. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 311. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 312. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 313. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 318. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 319. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 320. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 335. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 336. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 337. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 338. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 340. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 342. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 343. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 344. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 345. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 346. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 347. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 348. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 349. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 350. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 351. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 352. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 353. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 354. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 355. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 356. SAUDI ARAB

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Aminoglycosides market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Viatris Inc.
  • Fresenius Kabi AG
  • Hikma Pharmaceuticals PLC
  • Baxter International Inc.
  • Amneal Pharmaceuticals Inc.
  • Pfizer Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Limited

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.12 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.67 Billion
Compound Annual Growth Rate4.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Aminoglycosides Market Size, Share & Trends Analysis Report by Product (Neomycin, Tobramycin, Gentamicin), Route of Administration (Injectables, Feed, Intra-mammary), Application (Veterinary, Skin Infection), Region, with Growth Forecasts, 2025-2030 - Product Image

Aminoglycosides Market Size, Share & Trends Analysis Report by Product (Neomycin, Tobramycin, Gentamicin), Route of Administration (Injectables, Feed, Intra-mammary), Application (Veterinary, Skin Infection), Region, with Growth Forecasts, 2025-2030

  • Report
  • 105 Pages
  • Global
From
Aminoglycosides Market Report 2025 - Product Image

Aminoglycosides Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Aminoglycosides - Global Strategic Business Report - Product Image

Aminoglycosides - Global Strategic Business Report

  • Report
  • 402 Pages
  • Global
From
Aminoglycosides Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Aminoglycosides Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 87 Pages
  • Global
From
Antibacterial Drugs Market by Drug Class, Route Of Administration, Molecule Type, Spectrum Of Activity, Mechanism of Action, Formulation, Indication, Point of Sale, Distribution Channel - Global Forecast 2025-2030 - Product Image

Antibacterial Drugs Market by Drug Class, Route Of Administration, Molecule Type, Spectrum Of Activity, Mechanism of Action, Formulation, Indication, Point of Sale, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.